Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial
Jeffrey How(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center)
Cited by 4
Related Papers
Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the Circulation
|Molecular Cancer Research|2017|278
CRL4Cdt2 E3 Ubiquitin Ligase Monoubiquitinates PCNA to Promote Translesion DNA Synthesis
|Molecular Cell|2010|158
Overcoming Platinum Resistance in Preclinical Models of Ovarian Cancer Using the Neddylation Inhibitor MLN4924
|Molecular Cancer Therapeutics|2013|74
Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma
|Neoplasia|2011|71
Evaluation of EVI1 and EVI1s (Δ324) as potential therapeutic targets in ovarian cancer
|Gynecologic Oncology|2010|26